EPISODE · Jun 8, 2026 · 55 MIN
Episode 509: ASCO 2026 Review
from The Uromigos · host The Uromigos
This comprehensive podcast covers the latest advances in prostate, bladder, and kidney cancers from ASCO 2026, including new therapies, trial data, and practice-changing insights. Brian, Tom and Silke analyze recent studies, controversies, and future directions in GU oncology.
Embed this episode
NOW PLAYING
Episode 509: ASCO 2026 Review
0:00
55:12
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Uromigos?
This episode is 55 minutes long.
When was this The Uromigos episode published?
This episode was published on June 8, 2026.
Can I download this The Uromigos episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!